Thirty-eight patients were randomly divided into 2 groups; the intraosseous injection group of dexamethasone (4 mg) and the submucosal injection group. All surgeries were performed by one surgeon. Postoperative pain was evaluated by visual analog scale score immediately after surgery and on postoperative days 1, 3, and 7. Swelling (determined using two linear measurements) were assessed just before the surgery and on postoperative days 1, 3, and 7 by using a digital vernier caliper. Early healing of periodontal soft tissue wound was assessed by using Early Wound Healing Score (EHS) which composed of 3 parameters: clinical signs of re-epithelization (CSR), clinical signs of hemostasis (CSH), and clinical signs of inflammation (CSI) and were assessed on postoperative days 1, 7, and 14. Mouth opening (determined by measurement of the maximum inter-incisal distance) were assessed just before the surgery and on postoperative days 1, 3, and 7 by using a digital vernier caliper.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Enrollment
38
IO dexamethasone injection Dexamethasone 4 mg
SM dexamethasone injection Dexamethasone 4 mg
Outpatient Clinic of Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Alexandria University, Egypt
Alexandria, Azarita, Egypt
Change in mouth opening
determined by measurement of the maximum inter-incisal distance assessed by using a digital vernier caliper
Time frame: baseline, 1st, 3rd, 7th days
change in swelling
assessed by measuring two linear references (horizontal and vertical) with digital vernier caliper 1. Horizontal reference between the corner of the mouth and the tragus of the ear. 2. Vertical reference between the lateral canthus and the angle of the mandible.
Time frame: 1st, 3rd, 14th days
change in pain scores
Pain will be assessed by using a visual analog scale (VAS) (13) immediately after surgery and on postoperative days 1, 3, and 7.
Time frame: 1st, 3rd, 7th days
change in early healing of periodontal soft tissue wound
The EHS is composed of 3 parameters: 1. Clinical signs of re-epithelization (CSR). 2. Clinical signs of haemostasis (CSH). 3. Clinical signs of inflammation (CSI).
Time frame: 1st, 7th, 14th days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.